{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2020-09-23T00:00:00", "title": "AO 20-05", "url": "https://oig.hhs.gov/compliance/advisory-opinions/20-05/", "attachments": [{"title": "Advisory Opinion 20-05", "url": "https://oig.hhs.gov/documents/advisory-opinions/768/AO-20-05.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-20-05", "subagency": "Office of the Inspector General", "summary": "Regarding a pharmaceutical manufacturer's proposal to provide cost-sharing assistance directly to Medicare beneficiaries who are prescribed either of two formulations of its drug."}